ConductScience.org, home

Paper41809263

Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress.

Manoochehri H and 10 others. Asian J Pharm Sci, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress. Papers, record 41809263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41809263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress.
PubMed
Journal
Asian J Pharm Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.88, provisional
iCite
Revised in PubMed
2026-09-17
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Manoochehri HHamed
2La'ah ASAnita S
3Babaeizad AAli
4Sheykhhasan MMohsen
5Rostamipoor MMohadeseh
6Abbaspoor MMahdiyeh
7Nikravesh FFariba
8Mozaffari Khosravi SSamira
9Mahaki HHanie
10Tanzadehpanah HHamid
11Yang PPiao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References245

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136582304M2-like macrophage-derived exosomes facilitate metastasis in non-small-cell lung cancer by delivering integrin αVβ3.MedComm (2020)2023https://conductscience.org/library/papers/36582304PubMed
235163020Exosomal MALAT1 Derived from High Glucose-Treated Macrophages Up-Regulates Resistin Expression via miR-150-5p Downregulation.Int J Mol Sci2022https://conductscience.org/library/papers/35163020PubMed
336123730A review on exosomes application in clinical trials: perspective, questions, and challenges.Cell Commun Signal2022https://conductscience.org/library/papers/36123730PubMed
423170255Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands.Oncoimmunology2012https://conductscience.org/library/papers/23170255PubMed
535056304Microfluidic Approaches and Methods Enabling Extracellular Vesicle Isolation for Cancer Diagnostics.Micromachines (Basel)2022https://conductscience.org/library/papers/35056304PubMed
633713953Isolation of extracellular vesicles with combined enrichment methods.J Chromatogr B Analyt Technol Biomed Life Sci2021https://conductscience.org/library/papers/33713953PubMed
723584393Extracellular vesicles: biology and emerging therapeutic opportunities.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23584393PubMed
831963216Extracellular Vesicles for Cancer Therapy: Impact of Host Immune Response.Cells2020https://conductscience.org/library/papers/31963216PubMed
932547069A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer.Onco Targets Ther2020https://conductscience.org/library/papers/32547069PubMed
1034919343A brief history of nearly EV-erything - The rise and rise of extracellular vesicles.J Extracell Vesicles2021https://conductscience.org/library/papers/34919343PubMed
1133253966Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.Biomaterials2021https://conductscience.org/library/papers/33253966PubMed
1234560422M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.Biomaterials2021https://conductscience.org/library/papers/34560422PubMed
1336922504Engineered exosomes from different sources for cancer-targeted therapy.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36922504PubMed
1433107700Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.Thorac Cancer2020https://conductscience.org/library/papers/33107700PubMed
1530301470Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.BMC Med2018https://conductscience.org/library/papers/30301470PubMed
1627032035A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.JAMA Oncol2016https://conductscience.org/library/papers/27032035PubMed
1733093453Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity.Cell Death Dis2020https://conductscience.org/library/papers/33093453PubMed
1829689228Exosomes and Ectosomes in Intercellular Communication.Curr Biol2018https://conductscience.org/library/papers/29689228PubMed
1930723593Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.Oncoimmunology2019https://conductscience.org/library/papers/30723593PubMed
2036849892Extracellular vesicles derived from mesenchymal stem cells - a novel therapeutic tool in infectious diseases.Inflamm Regen2023https://conductscience.org/library/papers/36849892PubMed

See all 245 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42711596Extracellular vesicles for next-gen therapeutics and drug delivery.Mol Biomed2026https://conductscience.org/library/papers/42711596PubMed
42514925Proteomic Stability and Ex Vivo Compatibility of a Processed Phospholipoproteic Secretome-Derived Formulation.Pharmaceutics2026https://conductscience.org/library/papers/42514925PubMed
42253953Glioma-derived extracellular vesicles as drivers of immunotherapeutic resistance: mechanisms of immune reprogramming and metabolic intervention.Front Immunol2026https://conductscience.org/library/papers/42253953PubMed
42180894Exosomal P4HA3: a promising biomarker for diagnosis and prognosis in gastric cancer.Transl Cancer Res2026https://conductscience.org/library/papers/42180894PubMed
41948316Editorial: Immune-genetic dynamics in disease progression and therapeutic strategies.Front Immunol2026https://conductscience.org/library/papers/41948316PubMed
41299768
Therapeutic potential and mechanistic insights into adipose-derived stem cells and mesenchymal stem cell-derived exosomes in patients with Crohn's disease-associated fistulas: challenges and future perspectives.
Stem Cell Res Ther2025https://conductscience.org/library/papers/41299768PubMed
41281748Extracellular matrix dysregulation in aging, calcification, and cancer diseases: insights into cellular senescence, inflammation, and novel therapeutic strategies.Int J Biol Sci2025https://conductscience.org/library/papers/41281748PubMed

Download CSV of cited by

Genes61

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGFG13267PubTator's text mininghttps://conductscience.org/library/genes/3267NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ARF3377PubTator's text mininghttps://conductscience.org/library/genes/377NCBI Gene
ARF6382PubTator's text mininghttps://conductscience.org/library/genes/382NCBI Gene
BSG682PubTator's text mininghttps://conductscience.org/library/genes/682NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD63967PubTator's text mininghttps://conductscience.org/library/genes/967NCBI Gene
CD81975PubTator's text mininghttps://conductscience.org/library/genes/975NCBI Gene
CD823732PubTator's text mininghttps://conductscience.org/library/genes/3732NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD9928PubTator's text mininghttps://conductscience.org/library/genes/928NCBI Gene
CLDN31365PubTator's text mininghttps://conductscience.org/library/genes/1365NCBI Gene
CPNE38895PubTator's text mininghttps://conductscience.org/library/genes/8895NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene

See all 61 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41809263

GET https://conductscience.org/api/papers/v1/41809263/references?page=2